Radiology for the Non-Radiologist 2022

Radiology for the Non-Radiologist 2022
Mon Mar 28, 2022 - Thu Mar 31, 2022
7:30am-12:50pm EST
Sarasota, Florida
SEMLA-3620220328
Live
Open For Registration Expired

Live Webinar Access Information: 
Webinars are held via zoom and the Wednesday prior to the conference start date, an email will be sent with the zoom link.

We're sorry, but all tickets sales have ended because the event is expired.

Live Webinar Access Information: 
Webinars are held via zoom and the Wednesday prior to the conference start date, an email will be sent with the zoom link.

Presented By

Presenter

  • Ryan K. Lee, M.D., M.B.A. (Learn More)
    Clinical Associate Professor of Radiology, Sidney Kimmel Medical College, Thomas Jefferson University; Magnetic Resonance Medical Director, Director of Quality, Section Chief of Neuroradiology, Department of Radiology, Einstein Healthcare Network, Philadelphia, PA
  • Adam R. Guttentag, M.D. (Learn More)
    Associate Professor of Radiology and Radiologic Sciences, Cardiothoracic Radiology, Vanderbilt University Medical Center, Nashville, TN
  • Ryan J. Smith, M.D. (Learn More)
    Ryan J. Smith, M.D.  Clinical Assistant Professor of Radiology, Sidney Kimmel Medical School at Thomas Jefferson University; Diagnostic Radiology Residency Program Director and Vice Chair of Education, Einstein Medical Center Philadelphia, Einstein Healthcare Network, Philadelphia, PA

Course Outline

Day 1

Use and Interpretation of Thyroid Tests 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Integrate the serum tests for thyroid function.
  2. Interpret thyroid tests results that occur in clinical settings.
  3. Recommend the appropriate follow-up testing of abnormal thyroid tests and the frequency of these evaluations.
  4. Appraise the need to treat subclinical hypothyroidism or subclinical hyperthyroidism.

Evaluation and Treatment of Hypertensive Patients   

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Employ the non-pharmacologic treatment options to manage hypertension.
  2. Specify the pharmacologic treatment options for patients with compelling indications based upon JNC Guidelines.
  3. Formulate the therapeutic goal for controlling blood pressure in different patient populations and the combination of medications that can achieve that goal.
  4. Distinguish the side effect risks for each class of antihypertensive medications.

Approach to the Patient with Rheumatic Diseases 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Demonstrate the importance of the history and physical exam including patterns of joints involvement and extra-articular findings in evaluating patients with rheumatic diseases.
  2. Distinguish inflammatory (i.e. rheumatoid arthritis) and structural arthritis (i.e. osteoarthritis).
  3. Differentiate patterns of articular involvement associated with different arthritides.
  4. Utilize laboratory and radiological studies in the evaluation of patients with rheumatic diseases.

Lyme Disease and Other Topics in Rheumatology 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Apply CDC and Infectious Diseases Society of America Guidelines for the diagnosis, treatment, and prevention of Lyme disease.
  2. Evaluate skin rashes as manifestations of systemic diseases.
  3. Using the Guidelines of the Bone Research Society of the United Kingdom to prescribe appropriate therapy for patients with Paget’s disease of the bone.

Crystal Arthritis

Upon completion of this session, the participant should be able to: GL,COMP

  1. Demonstrate the clinical presentations and manifestations in the course of gout.
  2. Monitor and prescribe treatment for patients with gout according to the EULAR and ACR recommendations and guidelines.
  3. Demonstrate the clinical presentations, manifestations, and treatment of calcium pyrophosphate deposition disease (CPPD) and pseudogout.

Day 2

Rheumatoid Arthritis

Upon completion of this session, the participant should be able to: GL,COMP

  1. Demonstrate the role of genetics, environmental factors, immune cells, and proinflammatory cytokines in the pathogenesis of rheumatoid arthritis.
  2. Illustrate the clinical features, extra-articular manifestations, and complications of rheumatoid arthritis.
  3. Utilize and compare various methods of measuring disease activity in rheumatoid arthritis.
    Compare and contrast the mechanisms of action of current and emerging therapies for RA and prescribe treatment for patients with rheumatoid arthritis according to ACR guidelines
    .

Spondyloarthropathies  

Upon completion of this session, the participant should be able to: EBM,COMP

  1. Distinguish the clinical features of the different spondyloarthropathies to improve diagnostic accuracy.
  2. Utilize clinical features, laboratory studies, and radiological studies to make a diagnosis of axial spondyloarthropathy.
  3. Prescribe pharmacologic agents according to ACR and EULAR recommendations and evidence-based results from clinical trials for patients with spondyloarthropathies.

Septic Arthritis

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Determine the risk factors associated with septic arthritis.
  2. Utilize the British Society of Rheumatology Guidelines for management of the hot swollen joint in adults to differentiate septic arthritis from other causes of acute monoarticular arthritis.
  3. Utilize epidemiological and clinical clues to determine bacterial etiology in patients with septic arthritis.

Treating Patients with Type 2 Diabetes Mellitus 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Evaluate the therapeutic goals in treating type 2 diabetes and their impact on morbidity and mortality.
  2. Recommend the approach for choosing an oral hypoglycemic agent to treat type 2 diabetes.
  3. Specify the clinical situations that would require the use of insulin to treat type 2 diabetes and the probable dosage form and average amounts required for control of A1c.
  4. Develop the therapeutic options for preventing diabetic complications.

Chronic Obstructive Pulmonary Disease (COPD): Evaluation and Treatment 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Appraise patient specific data to determine if they meet diagnostic criteria for COPD.
  2. Analyze the role of cigarette smoking in the etiology and natural history of COPD.
  3. Formulate a treatment plan for the stages of COPD.
  4. Recommend the follow-up required to assess the therapeutic efficacy of the treatment options.

Day 3

Migraine Headaches – Update on Diagnosis and Treatment 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Construct the approach for evaluating a patient with possible migraine headaches.
  2. Assess the advantages of supportive therapy and lifestyle changes in treating migraine headaches compared to pharmacologic therapy.
  3. Appraise the pharmacologic options for treating the acute pain of a migraine headache.
  4. Recommend a prophylactic therapy regimen for patients with recurrent migraine headaches.

Osteoporosis: Treatment and Prevention 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Debate the importance of the risk factors for an osteoporosis fracture.
  2. Employ the diagnostic testing for patients at risk with osteoporosis.
  3. Select the therapeutic medication to treat osteoporosis based upon the indications and side effects.
  4. Assess the therapeutic role of repeating the DXA scan in patients treated for osteoporosis.

Treatment of Sexually Transmitted Infections 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Determine the appropriate diagnostic testing for complaints suggestive of a sexually transmitted infection.
  2. Select the therapy for the commonly encountered sexually transmitted infections.
  3. Formulate the follow-up testing and evaluations for sexually transmitted infections.
  4. Recommend the therapeutic options for preventing herpes simplex infections.

Outpatient Anticoagulation Issues, Part 1 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Manage outpatients on warfarin using current CHEST guidelines and The Joint Commission 2016 National Patient Safety Goals.
  2. Determine factors leading to alterations in the international normalized ratio (INR).
  3. Advise patients on the appropriate choice, duration, and intensity of anticoagulation in a variety of clinical scenarios.
  4. Develop a familiarity with the new oral anticoagulants.

Outpatient Anticoagulation Issues, Part 2

Upon completion of this session, the participant should be able to: EBM,COMP

  1. Develop an evidence-based approach on perioperative management of antithrombotic and anticoagulant medications.
  2. Recognize the proper use of IVC filters using evidence-based medicine.
  3. Develop a practical approach when transitioning patients on and off anticoagulants or switching between anticoagulants.
  4. Identify appropriate use of anticoagulant and antithrombic medications in combined therapy.

Day 4

Evaluation of the Patient with Syncope 

Upon completion of this session, the participant should be able to: GL,COMP

  1. Appraise the various etiologies of syncope.
  2. Use clues in the history and physical as well as simple office testing to risk stratify patients with syncope.
  3. Develop a plan for appropriate use of additional testing in patients with syncope to include indications for EP testing as per the AHA Syncope Algorithm and the ESC Guidelines.
  4. Assess the role of lifestyle measures, medication, and more invasive measures to prevent recurrent syncope.

Drug Interactions and Side Effects  

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Determine the most common mechanisms for drug interactions.
  2. Identify some of the most frequent culprit drugs such as Warfarin and Acetaminophen, AED’s, NSAIDs, and Statins.
  3. Counsel patients regarding some of the most frequent side-effects seen with commonly used medications.
  4. Employ The Joint Commission 2016 Ambulatory Care National Patient Safety Goals.

Peripheral Arterial Disease (PAD) – A Primary Care Perspective 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Assess the relationship between PAD and other forms of atherosclerosis.
  2. Determine which patients are at increased risk for PAD.
  3. Perform a focused history and physical examination to assess for PAD.
  4. Determine when to use ancillary testing.
  5. Develop a plan for managing patients with PAD utilizing evidence-based ACC/AHA and CHEST guidelines for exercise, medications, and revascularization.

Adult Health Screening and Immunizations – Evidence-Based Approach 

Upon completion of this session, the participant should be able to: EBM,GL,COMP

  1. Apply the evidence-based recommendations for preventive screening tests for adults.
  2. Determine the immunizations required for adults.
  3. Appraise the side effects of adult immunizations.
  4. Select the contraindications for each adult immunization and their alternative therapy.
  5. Plan when screening tests can be discontinued in adults.

Pain Treatment; Reducing Opioid Abuse; Medication Assisted Treatment of Opioid Use Disorder 

Upon completion of this session, the participant should be able to: GL,COMP

  1. Implement general principles and goals for the treatment of pain.
  2. Summarize the best practices for pharmacologic management of acute pain including potential benefits and risks of opioid analgesics.
  3. Describe the cultural change in approach pain management.
  4. Discuss the latest guidelines for pain management.
  5. Apply nonpharmacologic pain management strategies.
  6. Summarize ways to reduce opioid abuse.
  7. Describe the treatment options for patients with opioid used disorder.

Accreditation

AMA
American Medical Seminars, Inc. designates this live activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACEP

The American College of Emergency Physicians has completed its review and approved the activity, Radiology for the Non-Radiologist (activity number 3779).

This activity is approved for a maximum of 20 ACEP Category I credit(s) for occurrences of the same content offered within a 1-year time frame, if reported at the time the application is initially submitted.

AAFP

The AAFP has reviewed Radiology for the Non-Radiologist and deemed it acceptable for up to 20.00 Live AAFP Prescribed credits. Term of Approval is from 03/28/2022 to 03/31/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accommodations

HOTEL RESERVATION LINK

To arrange your stay, please use the above “Hotel Reservation Link.” The special room rate will be available on a first come first serve basis until the group block is sold-out.

Rent a Car with Enterprise or National:
To book your CME conference car rental and to receive special rates exclusively for AMS attendees, you may call or book online with our contracted companies, Enterprise/National

 



mail@ams4cme.com 1-866-267-4263

AMS Cancellation Policy: American Medical Seminars has implemented a Worry-Free Cancellation policy. Written cancellations received 30 or more days prior to the conference start date will be eligible for a full refund of the registration fee paid.  Cancellations received less than 30 days, please send an email to mail@ams4cme.com asking to be switched to a future conference. We are happy to transfer you to any conference scheduled to take place within the next two years. Even if you are not yet sure which conference you wish to attend. If you are an international attendee and need to cancel the seminar after an Invitation Letter has been sent, there is a $150.00 cancellation fee.

Disclaimer: In the event that AMS is required to cancel a live conference, registrants will receive a full refund within 7 business days. AMS is not responsible for charges associated with cancelled flights or hotel rooms.


Register